Thursday, March 8, 2018

Meeting between LIF and Hemoderivados Lab

Business meeting to strengthen the activities between both institutions. The visitors explored the new research area.

     Jorge Sttetler and Guillermo Cleti ( LIF’s Directors), and Horacio Coutaz (Trustee) received Pascual Fidelio (Director of LH-UNC*) and Maximiliano Flynn (Marketing Manager of LH-UNC).
     During the meeting, the attendants analyzed a list of different medicines which the Santa Fe’s Health Ministry frequently buys by public tender. Some of these might be produced through an associated work between LIF and LH-UNC.
     “The main idea is to use the capacities and specialization of both laboratories. Today, LIF produces powder and tablets. On the other hand, LH-UNC is specialized in low volume injectable drugs. We have talked about them complementing us,” expressed Guillermo Cleti.
     “We are here with the specific intention to continue linking both institutions, more and better. The exchange of experiences, the joint projects and the production of more medicines to improve the health and quality of life of people are our shared goals,” said Pascual Fidelio.
     “In Argentina, along with the history of the public production of medicines, the laboratories have never competed. We have always encouraged learning and working together. The availability and accessibility of safe and quality medicines are the objectives,” said Jorge Stettler.
     After meeting, the new research area was showed to the visitors. Cecilia Selis (LIF’s Technical Director) led the group through the facilities.

*LH-UNC: Laboratorio de Hemoderivados - Universidad Nacional de Córdoba

No comments: